Circulating levels of thrombopoietic and inflammatory cytokines in patients with clonal and reactive thrombocytosis

被引:71
作者
Hsu, HC [1 ]
Tsai, WH
Jiang, ML
Ho, CH
Hsu, ML
Ho, CK
Wang, SY
机构
[1] Vet Gen Hosp, Dept Med, Div Hematol, Taipei 11217, Taiwan
[2] Vet Gen Hosp, Dept Med Res, Taipei 11217, Taiwan
[3] Natl Yang Ming Univ, Taipei 112, Taiwan
来源
JOURNAL OF LABORATORY AND CLINICAL MEDICINE | 1999年 / 134卷 / 04期
关键词
D O I
10.1016/S0022-2143(99)90154-3
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The regulation of megakaryocytopoiesis and thrombopoiesis appears to be under the control of an array of hematopoietic growth factors. To determine the relationship between endogenous cytokine levels and circulating platelet counts, we measured the serum levels of both thrombopoietic and inflammatory cytokines in the peripheral brood and bone marrow samples from 70 patients with clonal thrombocytosis (CT) caused by myeloproliferative disorders, 28 patients with reactive thrombocytosis (RT), and 35 normal control subjects, The levels of thrombopoietin (TPO), interleukin-6 (IL-6), soluble IL-6 (sIL-6) receptor, IL-11, stem cell factor (SCF), IL-3, and IL-8 were determined by enzyme-linked immunosorbent assay (ELISA). Platelet counts were significantly higher in both CT and patients with RT (699 +/- 399 x 10(9)/L, P<.001; 642 +/- 200 x 10(9)/L, P<.001; respectively) as compared with the normal control subjects (240 +/- 47 x 10(9)/L). The concentrations of cytokines in the bone marrow correlated well with those in the peripheral blood. The endogenous levels of TPO, IL-6, and sIL-6 receptor were significantly higher in both CT and patients with RT than those in normal control subjects, The median level of IL-6 was significantly higher in patients with RT than in patients with CT (40 pg/mL vs 5 pg/mL; P <.001); however, there was no detectable difference in TPO and sIL-6 receptor levels between the two groups. Significantly higher levels of SCF and IL-8 were also found in patients with CT as compared with those found in normal control subjects (median 2460 pg/mL vs 1995 pg/mL, P <.05; 20 ng/mL vs 5 ng/mL, P =.001; respectively). Finally, IL-11 and IL-3 levels were undetectable in most patients with thrombocytosis. Our results reveal that the endogenous levels of TPO, IL-6, sIL-6 receptor, IL-8,and SCF are elevated in patients with CT or RT. These cytokines appear to be active mediators involved in the regulation of thrombopoiesis during clonal and reactive thrombocytosis.
引用
收藏
页码:392 / 397
页数:6
相关论文
共 45 条
  • [1] WORKING CLASSIFICATION OF CHRONIC MYELOPROLIFERATIVE DISORDERS BASED ON HISTOLOGICAL, HEMATOLOGICAL, AND CLINICAL FINDINGS
    BURKHARDT, R
    BARTL, R
    JAGER, K
    FRISCH, B
    KETTNER, G
    MAHL, G
    SUND, M
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 1986, 39 (03) : 237 - 252
  • [2] LEUKEMIA INHIBITORY FACTOR AND INTERLEUKIN-11 PROMOTE MATURATION OF MURINE AND HUMAN MEGAKARYOCYTES INVITRO
    BURSTEIN, SA
    MEI, RL
    HENTHORN, J
    FRIESE, P
    TURNER, K
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 1992, 153 (02) : 305 - 312
  • [3] THE INCIDENCE OF THROMBOTIC AND HEMORRHAGIC DISORDERS IN ASSOCIATION WITH EXTREME THROMBOCYTOSIS - AN ANALYSIS OF 129 CASES
    BUSS, DH
    STUART, JJ
    LIPSCOMB, GE
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 1985, 20 (04) : 365 - 372
  • [4] Thrombopoietin levels in patients with primary and reactive thrombocytosis
    Cerutti, A
    Custodi, P
    Duranti, M
    Noris, P
    Balduini, CL
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1997, 99 (02) : 281 - 284
  • [5] Differential mechanisms in the regulation of endogenous levels of thrombopoietin and interleukin-11 during thrombocytopenia: Insight into the regulation of platelet production
    Chang, M
    Suen, Y
    Meng, G
    Buzby, JS
    Bussel, J
    Shen, V
    vandeVen, C
    Cairo, MS
    [J]. BLOOD, 1996, 88 (09) : 3354 - 3362
  • [6] CHISTOLINI A, 1990, HAEMATOLOGICA, V75, P537
  • [7] COLOMBI M, 1991, CANCER-AM CANCER SOC, V67, P2926, DOI 10.1002/1097-0142(19910601)67:11<2926::AID-CNCR2820671136>3.0.CO
  • [8] 2-3
  • [9] INCIDENCE AND RISK-FACTORS FOR THROMBOTIC COMPLICATIONS IN A HISTORICAL COHORT OF 100 PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA
    CORTELAZZO, S
    VIERO, P
    FINAZZI, G
    DEMILIO, A
    RODEGHIERO, F
    BARBUI, T
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (03) : 556 - 562
  • [10] Which tests are most useful to distinguish between clonal and reactive thrombocytosis?
    Custodi, P
    Cerutti, A
    Balduini, CL
    [J]. AMERICAN JOURNAL OF MEDICINE, 1996, 101 (02) : 233 - 235